Cefotaxime

FDA Approved: * March 24, 2000
Pharm Company: * AM PHARM PARTNERS
Category: Antibiotics

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Cefotaxime Overview

Cefotaxime is an antibiotic used to treat a number of bacterial infections.[2] Specifically it is used to treat joint infections, pelvic inflammatory disease, meningitis, pneumonia, urinary tract infections, sepsis, gonorrhea, and cellulitis.[2] It is given either by injection into a vein or muscle.[2] Common side effects include nausea, allergic reactions, and inflammation at the site of injection.[2] Another side effect may inc...

Read more Cefotaxime Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Cefotaxime

Recent Cefotaxime Forums: RSS Feed

Cefetamet

There are some articles available about trials of Cefetamet as a cephalosporin antibiotic. Cefetamet pivoxil clinical pharmacokinetics. "Cefetamet pivoxil is an orally absorbed prodrug ester of the microbiologically active cephalosporin, cefetamet. The prodrug ester is completely hydrolysed to the active compound cefetamet on its first pass through the gut wall, the liver or both. Cefetamet is classified as a third generation cephalosporin with excellent activity against streptococci, Enterobacteriaceae, Neisseria and Haemophilus species. It has enhanced stability against beta-lactamases compared with penicillins and first and second generation cephalosporins. The antibacterial spectrum is comparable with that of cefotaxime except for its poor activity against staphylococci. Followi...

Updated

Possible Dosages for this and Related Drugs:

Cefotaxime
  • Injection: 10g, 10gm/vial, 1g, 1gm/vial, 20g, 20gm/vial, 2g, 2gm/vial, 500mg, 500mg/vial
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Cefotaxime: (15 results)

Sorted by National Drug Code
  • 0143-9930 Cefotaxime 500 mg/1 Intramuscular; Intravenous Injection, Powder, for Solution by West-ward Pharmaceutical Corp
  • 0143-9931 Cefotaxime 1 g/1 Intramuscular; Intravenous Injection, Powder, for Solution by West-ward Pharmaceutical Corp
  • 0143-9933 Cefotaxime 2 g/1 Intramuscular; Intravenous Injection, Powder, for Solution by West-ward Pharmaceutical Corp
  • 0143-9935 Cefotaxime 10 g/1 Intravenous Injection by West-ward Pharmaceutical Corp
  • 0409-0811 Cefotaxime 1 g/1 Intravenous Injection, Powder, for Solution by Hospira, Inc.
  • 0409-0812 Cefotaxime 2 g/1 Intravenous Injection, Powder, for Solution by Hospira, Inc.
  • 55648-947 Cefotaxime 500 mg/ml Intramuscular; Intravenous Injection, Powder, for Solution by Wockhardt Limited
  • 55648-948 Cefotaxime 2 g/ml Intramuscular; Intravenous Injection, Powder, for Solution by Wockhardt Limited
  • 55648-986 Cefotaxime 1 g/ml Intramuscular; Intravenous Injection, Powder, for Solution by Wockhardt Limited
  • 64679-947 Cefotaxime 500 mg/1 Intramuscular; Intravenous Injection, Powder, for Solution by Wockhardt USA LLC.
  • 64679-948 Cefotaxime 2 g/1 Intramuscular; Intravenous Injection, Powder, for Solution by Wockhardt USA LLC.
  • 64679-986 Cefotaxime 1 g/1 Intramuscular; Intravenous Injection, Powder, for Solution by Wockhardt USA LLC.
  • 68180-811 Cefotaxime 500 mg Intramuscular; Intravenous Injection, Powder, for Solution by Lupin Pharmaceuticals, Inc.
  • 68180-822 Cefotaxime 1 g/1 Intramuscular; Intravenous Injection, Powder, for Solution by Lupin Pharmaceuticals, Inc.
  • 68180-833 Cefotaxime 2 g/1 Intramuscular; Intravenous Injection, Powder, for Solution by Lupin Pharmaceuticals, Inc.

Other drugs which contain Cefotaxime or a similar ingredient: (1 result)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 10 December 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA